New blood test may help Fine-Tune diabetes treatment faster

NCT ID NCT05227677

Completed Knowledge-focused Sponsor: Asahi Kasei Therapeutics Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether using a blood marker called glycated albumin (GA) to guide diabetes treatment works better than the usual HbA1c test. 200 adults newly diagnosed with type 2 diabetes were split into two groups: one where doctors used GA levels to adjust medication, and another where they followed standard guidelines. The goal was to see if the GA-guided group achieved better blood sugar control after 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES MELLITUS

Contacts and locations

Show contact details

Locations

Beijing Haidian Hospital

Beijing, China
Beijing Pinggu District Hospital

Beijing, China
Beijing Shijingshan Hospital

Beijing, China
Beijing Tiantan Hospital, Capital Medical University

Beijing, China
Civil Aviation General Hospital

Beijing, China
Peking University People's Hospital

Beijing, China
The third people's hospital of DATONG

Datong, Shanxi, China